Literature DB >> 15305412

Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Iwao Ikai1, Shigeki Arii, Masamichi Kojiro, Takafumi Ichida, Masatoshi Makuuchi, Yutaka Matsuyama, Yasuni Nakanuma, Kiwamu Okita, Masao Omata, Kenichi Takayasu, Yoshio Yamaoka.   

Abstract

BACKGROUND: Advances in the diagnosis and surgical treatment of hepatocellular carcinoma (HCC) have improved the prognosis for patients with HCC who undergo liver resection. The objective of this study was to evaluate prognostic predictors for patients with HCC who underwent liver resection in a Japanese nationwide data base.
METHODS: In this study, the authors analyzed 12,118 patients with HCC in a Japanese nationwide data base who underwent liver resection between 1990 and 1999 and compared them with a previous analysis of patients between 1982 and 1989. All patients were evaluated for prognostic factors.
RESULTS: During the last decade, the increases in patients who were without hepatitis B virus surface antigen, who had small tumors, and who had portal vein invasion were noted. The 5-year overall survival rates for patients with HCC improved to 50.5%, compared with < 40% in the previous analysis. A multivariate analysis using a stratified Cox proportional hazards model according to associated liver disease indicated that age, degree of liver damage, alpha-fetoprotein level, maximal tumor dimension, number of tumors, intrahepatic extent of tumor, extrahepatic metastasis, portal vein invasion, hepatic vein invasion, surgical curability, and free surgical margins were independent prognostic predictors for patients with HCC. Operative mortality decreased from 2.3% in 1990-1991 to 0.6% in 1998-1999.
CONCLUSIONS: Outcomes and operative mortality rates in patients with HCC improved during the last decade. Age, degree of liver damage, alpha-fetoprotein level, maximal tumor dimension, number of tumors, intrahepatic extent of tumor, extrahepatic metastasis, portal vein invasion, hepatic vein invasion, surgical curability, and free surgical margins were prognostic factors for patients with HCC who underwent liver resection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305412     DOI: 10.1002/cncr.20426

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  131 in total

1.  Radiological assessment of hepatic vein invasion by hepatocellular carcinoma using combined computed tomography hepatic arteriography and computed tomography arterial portography.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

Review 2.  Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging.

Authors:  Mohamed Bouattour; Audrey Payancé; Johanna Wassermann
Journal:  World J Hepatol       Date:  2015-09-18

3.  Central Hepatectomy Still Plays an Important Role in Treatment of Early-Stage Centrally Located Hepatocellular Carcinoma.

Authors:  Chun-Han Chen; Tzu-Hao Huang; Cheng-Chih Chang; Wei-Feng Li; Ting-Lung Lin; Chih-Chi Wang
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

Review 4.  Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.

Authors:  Masami Minagawa; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

5.  Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?

Authors:  Honsoul Kim; Mi-Suk Park; Jin Young Choi; Young Nyun Park; Myeong-Jin Kim; Kyung Sik Kim; Jin Sub Choi; Kwang-Hyub Han; EunJu Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

6.  Optimal treatment for hepatocellular carcinoma in the cirrhotic liver.

Authors:  S A White; D M Manas; S G Farid; K R Prasad
Journal:  Ann R Coll Surg Engl       Date:  2009-10       Impact factor: 1.891

7.  Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda; Seiji Okuda; Katsuhiko Otobe; Kenichi Takahashi
Journal:  Eur Radiol       Date:  2014-06-22       Impact factor: 5.315

8.  Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Seiji Okuda; Sadanobu Ogawa; Takumi Igura; Yasuharu Imai
Journal:  J Gastroenterol       Date:  2014-02-22       Impact factor: 7.527

9.  Laparoscopic versus open liver resection for hepatocellular carcinoma in posterosuperior segments.

Authors:  Le Xiao; Lun-jian Xiang; Jian-wei Li; Jian Chen; Yu-dong Fan; Shu-guo Zheng
Journal:  Surg Endosc       Date:  2015-04-22       Impact factor: 4.584

Review 10.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.